Oxford-AstraZeneca COVID-19 vaccine is a two-dose vaccine which has been jointly developed by the Oxford Vaccine Group and pharmaceutical company AstraZeneca to target the SARS-CoV-2 virus.
Talking about the symptoms, the doctors said that most of the recipients complained about rare skin rashes at the injection site with small localized blisters.
Low levels of neutralising antibodies from the current vaccines are unlikely to be sufficient to neutralise the Omicron variant, say experts.
Worried about the Delta variant of COVID-19? Two doses of Covishield and Pfizer COVID-19 vaccines may be 90% effective against the deadly variant.
The Delta variant which first emerged in India in 2020 and subsequently spread globally within a short time period is also responsible for the ferocious second wave of coronavirus that ravaged the country earlier this year.
Four new side effects linked with AstraZeneca also known as Covisheild in India have been listed by the experts. See if you have any of them.
AstraZeneca is also known as Covishield in India. The vaccine has been linked with causing rare neurological disorders. Read on to find out everything.
Blood clotting has been reported in some individuals after receiving COVID-19 vaccines. This condition is also known as Thrombosis.
According to the new study, second dose of AstraZeneca vaccine will not lead to any type of blood clotting or thrombosis with thrombocytopenia syndrome (TTS).
Got jabbed with the COVID-19 vaccines? A new study by Lancet has revealed that the antibodies start declining after 10 weeks. Read on to know more.
In two separate studies, researchers have found cases of a rare neurological disorder in recipients of AstraZeneca's COVID-19 vaccine. Read on to know more.
The Pfizer-BioNTech vaccine offered better protection against the Delta variant compared to the Oxford-AstraZeneca preventive, known as Covishield in India.
On June 11, Italy restricted the use of AstraZeneca doses to those aged 60 years and above, after a teenager who had received the shot died from a rare form of blood clotting.
The woman had received an initial dose of AstraZeneca vaccine on May 25. She died on Thursday. Reports said she had low blood platelet count and was on double hormone therapy before the vaccination.
The European Medicines Agency (EMA) has released new guidelines recommending physicians not to use heparin to treat uncommon blood clots in people who received AstraZeneca or Johnson & Johnson vaccines.
Rare blood clotting which is also known as thrombosis is a reported side effect that is being reported by the recipients of the AstraZeneca COVID-19 vaccine. Here's all you need to know about the disorder.
A whopping 57.2 per cent and 50.9 per cent reported tenderness after the first and second dose of Pfizer vaccine, and 49.3 per cent after the first dose of AstraZeneca vaccine, the researchers said.
A Sputnik V study has claimed that there are more post-vaccination deaths from Pfizer COVID-19 vaccines than from AstraZeneca shots. Read on to know more.
Oxford-AstraZeneca COVID-19 vaccine is a two-dose vaccine which has been jointly developed by the Oxford Vaccine Group and pharmaceutical company AstraZeneca to target the SARS-CoV-2 virus.
Talking about the symptoms, the doctors said that most of the recipients complained about rare skin rashes at the injection site with small localized blisters.
Low levels of neutralising antibodies from the current vaccines are unlikely to be sufficient to neutralise the Omicron variant, say experts.
Worried about the Delta variant of COVID-19? Two doses of Covishield and Pfizer COVID-19 vaccines may be 90% effective against the deadly variant.
The Delta variant which first emerged in India in 2020 and subsequently spread globally within a short time period is also responsible for the ferocious second wave of coronavirus that ravaged the country earlier this year.
Four new side effects linked with AstraZeneca also known as Covisheild in India have been listed by the experts. See if you have any of them.
AstraZeneca is also known as Covishield in India. The vaccine has been linked with causing rare neurological disorders. Read on to find out everything.
Blood clotting has been reported in some individuals after receiving COVID-19 vaccines. This condition is also known as Thrombosis.
According to the new study, second dose of AstraZeneca vaccine will not lead to any type of blood clotting or thrombosis with thrombocytopenia syndrome (TTS).
Got jabbed with the COVID-19 vaccines? A new study by Lancet has revealed that the antibodies start declining after 10 weeks. Read on to know more.
In two separate studies, researchers have found cases of a rare neurological disorder in recipients of AstraZeneca's COVID-19 vaccine. Read on to know more.
The Pfizer-BioNTech vaccine offered better protection against the Delta variant compared to the Oxford-AstraZeneca preventive, known as Covishield in India.
On June 11, Italy restricted the use of AstraZeneca doses to those aged 60 years and above, after a teenager who had received the shot died from a rare form of blood clotting.
The woman had received an initial dose of AstraZeneca vaccine on May 25. She died on Thursday. Reports said she had low blood platelet count and was on double hormone therapy before the vaccination.
The European Medicines Agency (EMA) has released new guidelines recommending physicians not to use heparin to treat uncommon blood clots in people who received AstraZeneca or Johnson & Johnson vaccines.
Rare blood clotting which is also known as thrombosis is a reported side effect that is being reported by the recipients of the AstraZeneca COVID-19 vaccine. Here's all you need to know about the disorder.
A whopping 57.2 per cent and 50.9 per cent reported tenderness after the first and second dose of Pfizer vaccine, and 49.3 per cent after the first dose of AstraZeneca vaccine, the researchers said.
A Sputnik V study has claimed that there are more post-vaccination deaths from Pfizer COVID-19 vaccines than from AstraZeneca shots. Read on to know more.
Logout 
